Vascepa® (icosapent ethyl) 26% Reduction in Key Secondary Composite Endpoint of Cardiovascular Death, Heart Attacks and Stroke Demonstrated in REDUCE-IT™ Supports 25% Overall Reduction in Five-Poin

Go back to Vascepa® (icosapent ethyl) 26% Reduction in Key Secondary Composite Endpoint of Cardiovascular Death, Heart Attacks and Stroke Demonstrated in REDUCE-IT™ Supports 25% Overall Reduction in Five-Poin
Amarin Corp Plc (NASDAQ: AMRN) Delayed: 11.51 +0.03 (0.26%)
Previous Close $11.48    52 Week High $3.65 
Open $11.60    52 Week Low $1.24 
Day High $11.67    P/E N/A 
Day Low $11.46    EPS $0.00 
Volume 37,945